Methyldopa Aspen Pharma Trading (Anhydrous Methyldopa)

After oral intake, methyldopa is converted to the active metabolite alpha‑methylnorepinephrine. This metabolite stimulates central α2‑adrenergic receptors in the brainstem, which reduces sympathetic nervous system activity. The resulting decrease in peripheral vascular resistance and heart‑rate output leads to a gradual reduction in arterial blood pressure.

The specific dose of methyldopa is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made during treatment to achieve the desired blood‑pressure target while monitoring for side effects.

Methyldopa is classified as pregnancy category B, indicating that it has been used extensively in pregnant women without evidence of fetal harm. It is considered one of the safer antihypertensives for gestational hypertension and preeclampsia. Limited data are available for breastfeeding, and the decision to continue therapy should be made by the healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Methyldopa belongs to the alpha‑2 adrenergic agonist class, which lowers blood pressure by reducing central sympathetic outflow. Compared with beta‑blockers or calcium‑channel blockers, methyldopa has a slower onset and is often preferred in pregnancy because of its safety profile. It may cause more sedation and dry‑mouth symptoms, whereas other classes have different side‑effect patterns.

Methyldopa tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Methyldopa is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal upset. Patients should follow the dosing schedule prescribed by their healthcare professional and not alter the timing without medical advice.

The most serious adverse events include severe hypotension, which can cause dizziness or fainting, hepatic dysfunction or jaundice, and hemolytic anemia. Patients should be monitored for signs of liver injury (e.g., yellowing of skin or eyes) and for unexplained fatigue or pallor that could indicate anemia.

Methyldopa is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in individuals with severe liver disease, significant renal impairment, or a history of autoimmune disorders such as systemic lupus erythematosus, as the medication may exacerbate these conditions.